Frederik Enggrob Lørval
Frederik Enggrob Lørval@FrameInvestment

Performance
All

12.35%2025
2025
23.75%2024
2024
57.65%2023
2023
-13.93%2022
2022
1.64%2021
2021
57.6%0%-57.6%
Top
Frederik Enggrob Lørval
𝟑 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐭𝐨 𝐖𝐚𝐭𝐜𝐡 𝐓𝐡𝐢𝐬 𝐒𝐮𝐦𝐦𝐞𝐫 🌞 Summer is around the corner, and many investors are shifting focus to travel plans and sunshine. But while we may take a break, the markets certainly won’t. As you enjoy some well-earned downtime, here are three important... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
𝐒𝐭𝐚𝐲 𝐂𝐚𝐥𝐦 𝐢𝐧 𝐚𝐧 𝐔𝐧𝐜𝐞𝐫𝐭𝐚𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 It honestly feels like riding a roller coaster without a seatbelt when Trump starts talking about tariffs and economic policy. One moment the market drops 10% after one of his statements, and the next week we’re right back where we started... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
Edited
𝐍𝐨𝐯𝐨 𝐍𝐨𝐫𝐝𝐢𝐬𝐤 𝐓𝐚𝐤𝐞𝐬 𝐚 𝐇𝐢𝐭: 𝐖𝐡𝐲 𝐘𝐨𝐮 𝐒𝐡𝐨𝐮𝐥𝐝𝐧'𝐭 𝐏𝐚𝐧𝐢𝐜 Novo Nordisk's stock has experienced a significant drop of approximately 10% today, following Eli Lilly's impressive reveal of their new obesity pill. But before you start hitting the panic button, let's... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐈𝐧𝐝𝐞𝐩𝐞𝐧𝐝𝐞𝐧𝐜𝐞 The current actions from the USA have forced Europe to focus on strategic independence, driven by de-globalisation, increased defence budgets, and a renewed emphasis on domestic resilience. This shift offers exciting... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
📈 𝐌𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲: 𝐅𝐢𝐧𝐝𝐢𝐧𝐠 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐫𝐞𝐚𝐜𝐭𝐢𝐨𝐧𝐬 My investment approach is primarily built on diversification across industries and global markets, with a strong focus on tech, AI, and pharma as I believe these sectors... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
Edited
⚠️ 𝐓𝐞𝐜𝐡 𝐒𝐭𝐨𝐜𝐤𝐬 𝐢𝐧 𝐅𝐫𝐞𝐞𝐟𝐚𝐥𝐥: 𝐂𝐡𝐢𝐧𝐚’𝐬 𝐀𝐈 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐢𝐬 𝐒𝐡𝐚𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐖𝐞𝐬𝐭? The tech market is in the red today, with AI-focused companies taking the biggest hit. $NVDA (NVIDIA Corporation) the king of the AI sector, is down by over 10%. Over in Europe,... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
Edited
𝟐𝟎𝟐𝟒 𝐘𝐞𝐚𝐫 𝐢𝐧 𝐑𝐞𝐯𝐢𝐞𝐰: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 & 𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 🚀 As we wrap up 2024, it's time to reflect on a year packed with surprises, challenges, and incredible opportunities. The markets delivered plenty of excitement, and I’m proud to share... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐏𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗨𝗽𝗱𝗮𝘁𝗲 As 2024 comes to an end, it’s clear that this year has been highly favorable for investors. However, looking across geographies, the year has also highlighted historically significant disparities between the world’s regions. As illustrated by the... Show More
Like CommentShare
null
.
Frederik Enggrob Lørval
Edited
𝐍𝐨𝐯𝐨 𝐍𝐨𝐫𝐝𝐢𝐬𝐤: 𝐒𝐡𝐨𝐮𝐥𝐝 𝐲𝐨𝐮 𝐛𝐮𝐲 𝐭𝐡𝐞 𝐝𝐢𝐩? Novo Nordisk’s stock is down nearly 30% since its peak in late June, marking the largest drop for the stock since 2016. For investors, this raises the question: Is this a golden buying opportunity, or should investors be worried? 𝑻𝒓𝒊𝒈𝒈𝒆𝒓𝒔... Show More
Like CommentShare
1 reply
null
.
Frederik Enggrob Lørval
𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐔𝐩𝐝𝐚𝐭𝐞 𝐚𝐧𝐝 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 𝐓𝐢𝐩𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐋𝐨𝐧𝐠 𝐓𝐞𝐫𝐦 I'm excited to share that our portfolio is up by +23% year-to-date, maintaining an average risk score of 4. Furthermore I have 216 copiers who have invested an average of $1,400+ each. When facing... Show More
Like CommentShare
1 reply
null
.

About FrameInvestment
Denmark
Strategy: Value

Msc. in Finance & Accounting Long-term Danish investor.
Show Full Bio
174 Copiers
1.9K Followers